| Upali Seneviratne, MD | |
|
114 Woodland St, Hartford, CT 06105-1208 | |
| (860) 714-6654 | |
| (860) 714-8110 |
| Full Name | Upali Seneviratne |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 114 Woodland St, Hartford, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174573729 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 016963 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Upali Seneviratne, MD 114 Woodland St, Hartford, CT 06105-1208 Ph: (860) 714-6654 | Upali Seneviratne, MD 114 Woodland St, Hartford, CT 06105-1208 Ph: (860) 714-6654 |
News Archive
A report released last week by the Presidential Commission for the Study of Bioethical Issues examining federally sponsored research involving human volunteers, called "Moral Science: Protecting Participants in Human Subjects Research," said that "current rules and regulations provide adequate safeguards to mitigate risk," "recommended 14 changes to current practices to better protect research subjects, and called on the federal government to improve its tracking of research programs supported with taxpayer dollars," according to a Commission press release.
ValueRich, Inc. announced today that the company has commenced litigation against China Pharmaceuticals, a publicly traded company under the symbol for breach of contract and other related claims. ValueRich alleges ownership of 20% of the outstanding shares of China Pharmaceuticals "pursuant to a May 2009 Consulting Agreement between ValueRich and Xian Pharmaceuticals, Ltd, the Chinese-based operating company for China Pharmaceuticals."
AVANIR Pharmaceuticals, Inc. today announced that it has received a "Notice of Allowance" from the United States Patent and Trademark Office (USPTO) announcing that it intends to grant the Company a new patent, extending the period of commercial exclusivity for its lead drug candidate Zenvia™ well into 2025.
PerkinElmer Inc. agreed to buy SIRION Biotech GmbH, a provider of viral vector-based technologies that drive improved delivery performance for cell and gene therapies. The acquisition is expected to close during the third quarter of 2021.
A collaboration, led by scientists at the Garvan Institute of Medical Research and the University of New South Wales (UNSW) in Sydney, has discovered the first risk gene specifically for bipolar disorder, also known as manic-depressive illness. This means that people who have a particular form of this gene are twice as likely to develop the disease.
› Verified 7 days ago
Phillip Dennen, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 114 Woodland St, Hartford, CT 06105 Phone: 860-714-6654 Fax: 860-714-8110 | |
Frank J Setter, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 114 Woodland St, Hartford, CT 06105 Phone: 860-714-6654 Fax: 860-714-8110 | |
Nitish Gupta, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 80 Seymour St, Hartford, CT 06106 Phone: 860-545-5000 | |
Adam Jason Sachs, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 80 Seymour St, Hartford, CT 06102 Phone: 516-521-8645 | |
Ethan Kim, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 80 Seymour St, Hartford, CT 06106 Phone: 860-545-5000 | |
Roxanne Zarmsky, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 114 Woodland St, Hartford, CT 06105 Phone: 860-714-6654 Fax: 860-714-8110 | |
Dr. Saadia Zafar, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 114 Woodland St, Hartford, CT 06105 Phone: 860-714-6654 |